Loading...
XHKG
3933
Market cap3.27bUSD
Dec 05, Last price  
12.92HKD
1D
0.62%
1Q
-27.33%
Jan 2017
144.70%
IPO
297.54%
Name

United Laboratories International Holdings Ltd

Chart & Performance

D1W1MN
XHKG:3933 chart
P/E
8.70
P/S
1.68
EPS
1.35
Div Yield, %
3.19%
Shrs. gr., 5y
2.07%
Rev. gr., 5y
10.39%
Revenues
13.76b
+0.14%
2,086,097,2162,430,926,9343,307,047,9564,088,081,9545,541,863,1925,183,778,6825,653,764,4645,971,793,4366,422,409,9616,445,983,2436,077,944,0006,826,645,0007,510,586,0008,392,600,0008,772,488,0009,703,438,00011,334,262,00013,739,879,00013,758,937,000
Net income
2.66b
-1.54%
174,307,439478,199,761378,765,722476,713,112830,200,94584,391,079130,422,79237,536,441544,615,84492,411,554-272,363,00081,758,000682,928,000641,764,000702,989,000988,098,0001,581,094,0002,701,350,0002,659,704,000
CFO
3.20b
+31.15%
286,241,898337,572,611610,511,854653,134,902569,463,560411,542,580475,737,1771,155,133,1161,400,007,7651,515,919,1521,074,464,000769,945,0001,213,239,0001,801,184,0001,567,826,0001,542,551,0002,030,543,0002,439,438,0003,199,302,000
Dividend
Jul 08, 20250.42886 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
URL
http://www.tul.com.cn/
IPO date
Jun 15, 2007
Employees
14,000
Domiciled in
HK
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT